How the target determines the nature of the effect
The relationship between the drug's site of action and its ultimate clinical effect is a fundamental concept in pharmacology. The type of effect on the microflora strictly depends on the specific structure targeted by the drug.
Two main types of action are distinguished:
- Bactericidal effect. The drug causes irreversible damage and complete cell death. This occurs when targets are structures critical for survival: the cell wall, the cytoplasmic membrane (disruption of its permeability), or RNA synthesis processes.
- Bacteriostatic effect. The growth and reproduction of the pathogen are halted, but the cell itself remains alive. This effect is typical of drugs that disrupt intracellular protein synthesis at the ribosomal level.
Understanding this correlation allows for accurate prediction of the results of antimicrobial therapy.
Disruption of cell wall and membrane synthesis
A significant portion of antimicrobials aims to destroy the outer envelopes of the microorganism. Blocking the formation of these structures always leads to a bactericidal effect.
1. Action on the cell wall These drugs affect the outer envelope of the bacterium, preventing the formation of a rigid framework or disrupting its integrity. As a result, the cell loses protection and is destroyed. This group includes:
- Beta-lactam antibiotics (the primary and most extensive class);
- Glycopeptide antibiotics;
- Various drugs from other groups: cycloserine, bacitracin, fosfomycin.
2. Destabilization of the cytoplasmic membrane This group of drugs destabilizes the membrane, critically altering its permeability. Vital components leave the cell, leading to its death. Membrane-active agents include:
- Polymyxins;
- Polyene antibiotics (drugs with pronounced antifungal activity);
- Aminoglycosides (a unique group with a dual mechanism: in addition to affecting protein synthesis, they disrupt membrane permeability).
Blockade of metabolism and protein synthesis
For active reproduction, bacteria must constantly synthesize new protein molecules and nucleotides. Interference with intracellular processes deprives them of this ability.
Disruption of metabolism (folic acid synthesis) Drugs block successive stages of the conversion of para-aminobenzoic acid (PABA) into active forms of folic acid, which are absolutely essential for nucleotide synthesis. The process is inhibited at two stages:
- First stage: Conversion of PABA to dihydrofolic acid (DHFA). This step involves sulfonamides, which act as inhibitors of dihydropteroate synthase.
- Second stage: Conversion of DHFA to tetrahydrofolic acid (THFA) involving the enzyme dihydrofolate reductase. This step is blocked by trimethoprim.
Disruption of protein synthesis at the ribosomal level Drugs bind to specific subunits of the bacterial ribosome, physically blocking mRNA translation. The nature of the action is in the vast majority of cases bacteriostatic. Typical protein synthesis inhibitors include macrolides, tetracyclines, lincosamides, and chloramphenicol. An exception to the rule is aminoglycosides, which, despite acting on ribosomes, exert a pronounced bactericidal effect.
Impact on the genetic apparatus
A distinct category of medications acts directly on the genetic apparatus of the bacterial cell, blocking the processes of copying and reading genetic information (nucleic acids).
Interference with this complex machinery leads to rapid death of the microorganism, which is why such drugs possess a bactericidal type of action. A classic example of disrupted RNA synthesis is the drug rifampicin.
To memorize antibiotic targets, imagine a fortress siege: first, the walls (cell wall) and gates (membrane) are battered, then provisions are cut off (metabolism/folic acid), the forges are smashed (ribosomes/protein), and the blueprints are destroyed (nucleic acids).
Class and exam questions
Why do drugs that disrupt cell wall synthesis act bactericidally?
Destruction of the outer envelope or prevention of its formation leads to irreversible damage to bacterial integrity, causing the cell to die.
What is the uniqueness of the mechanism of action of aminoglycosides?
They possess a dual action: they disrupt the permeability of the cytoplasmic membrane and block protein synthesis at the ribosomal level. Unlike other protein synthesis inhibitors, they act in a bactericidal manner.
How do sulfonamides affect bacterial metabolism?
They act on dihydropteroate synthase, blocking the first stage of the conversion of para-aminobenzoic acid (PABA) to dihydrofolic acid. This halts nucleotide synthesis.
What else to study on this topic
- Structural features of the cell wall in Gram-positive and Gram-negative bacteria
- The mechanism of mRNA translation on bacterial ribosomal subunits
- Differences between bactericidal and bacteriostatic effects in clinical practice
- The role of folic acid in bacterial nucleotide synthesis
- Mechanisms of bacterial resistance to beta-lactam antibiotics
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Mechanisms of Action of Antibiotics" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antibacterial Chemotherapeutic Agents"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.